TSHA logo
Taysha Gene Therapies, Inc.(TSHA)
Last print unknown agoAbout this dataData status
$3.94▲0.32 (8.84%)Stale · unknown oldEarnings · Nov 3

TSHA Other Income/Expenses (Net)

$3.53MTTM · USD

Period ending:

TSHA FY Other Income/Expenses (Net)USD
TSHA FY Other Income/Expenses (Net)2019-12-31: $0.002020-12-31: -$17.01M2021-12-31: -$1.26M2022-12-31: -$39.99M2023-12-31: -$39.13M2024-12-31: $2.16M2025-12-31: $1.50M$2.16M-$39.99M
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TSHA other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Taysha Gene Therapies Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
1,503,000
2,161,000
-39,127,000
-39,987,000
-1,256,000
-17,009,000
0

Compare other income/expenses (net)

All TSHA financial metrics · TSHA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.